Pursuant to section 11(1), the MyCC was encouraged to conduct a market review on the pharmaceutical sector as the demand for essential medicines is inelastic whereby consumers would purchase it despite the hike in prices. This review explored the market structure across the supply chain, competition level and possible anti-competitive conduct within the pharmaceutical sector.